Advanced Medical Solutions Grp PLC Director/PDMR and PCA Shareholding (0989N)

TIDMAMS

RNS Number : 0989N

Advanced Medical Solutions Grp PLC

03 May 2018

 
   3 May 2018 
 

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Director/PDMR and PCA Shareholding

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that it was notified on 30 April 2018 that Simon Coates, who is a PDMR, following the successful achievement of certain performance criteria, had on 30 April 2018 exercised and sold 28,193 options from the Long Term Incentive Plan (LTIP). His beneficial ownership remains unchanged.

The Company further announces that it was notified on 30 April 2018 that Jeff Willis, who is a PDMR, following the successful achievement of certain performance criteria, had on 30 April 2018 exercised and sold 40,350 options from the Long Term Incentive Plan (LTIP). His beneficial ownership remains unchanged.

Long Term Incentive Plan (LTIP)

 
 PDMR            No. of LTIPs   LTIPs exercised   Ordinary   Ordinary    LTIPs after 
                  prior to                         Shares     shares      exercise 
                  exercise                         sold       retained 
--------------  -------------  ----------------  ---------  ----------  ------------ 
 Simon Coates 
  PDMR           84,275         28,193            28,193     Nil         56,082 
--------------  -------------  ----------------  ---------  ----------  ------------ 
 Jeff Willis 
  PDMR           156,678        40,350            40,350     Nil         116,328 
--------------  -------------  ----------------  ---------  ----------  ------------ 
 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  ------------------------------------------------------- 
 a)   Name: Simon Coates 
---  ------------------------------------------------------- 
 2.   Reason for the notification 
---  ------------------------------------------------------- 
 a)   Position/status: PDMR 
---  ------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  ------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  ------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  ------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  ------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Exercise of 28,193 shares from the Long Term 
                Incentive Plan 
 
 
           *    Sale of 28,193 Ordinary Shares of 5p 
---  ------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)     Volume(s) 
       -----------  ---------- 
        GBP3.0677    28,193 
       -----------  ---------- 
---  ------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: 28,193 
       Aggregated price: GBP3.0677 
---  ------------------------------------------------------- 
 e)   Date of the transaction: 30/04/2018 
---  ------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  ------------------------------------------------------- 
 
 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  ------------------------------------------------------- 
 a)   Name: Jeff Willis 
---  ------------------------------------------------------- 
 2.   Reason for the notification 
---  ------------------------------------------------------- 
 a)   Position/status: PDMR 
---  ------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  ------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  ------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  ------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  ------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Exercise of 40,350 shares from the Long Term 
                Incentive Plan 
 
 
           *    Sale of 40,350 Ordinary Shares of 5p 
---  ------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)     Volume(s) 
       -----------  ---------- 
        GBP3.0677    40,350 
       -----------  ---------- 
---  ------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: 40,350 
       Aggregated price: GBP3.0677 
---  ------------------------------------------------------- 
 e)   Date of the transaction: 30/04/2018 
---  ------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  ------------------------------------------------------- 
 

- End -

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group                Tel: +44 (0) 
  plc                                             1606 545508 
 Chris Meredith, Chief Executive 
  Officer 
  Mary Tavener, Chief Financial 
  Officer 
 
 Consilium Strategic Communications              Tel: +44 (0) 
                                                 20 3709 5700 
 Mary-Jane Elliott / Matthew Neal     [e-mail] 
  / Philippa Gardner 
 
 Investec Bank PLC (NOMAD & Broker)              Tel: +44 (0) 
                                                 20 7597 5970 
 Daniel Adams / Patrick Robb / 
  Gary Clarence 
 

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal(R) , LiquiBand(R) and RESORBA(R) as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 600 employees. For more information, please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLLFFDERIVIIT

(END) Dow Jones Newswires

May 03, 2018 13:29 ET (17:29 GMT)